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Introduction   Large inter-donor differences exist in human mes-
enchymal stem cell (hMSC) yield and the response of these cells to 
osteogenic stimuli. The source of these differences may be clinical 
differences in stem cell characteristics between individuals or the 
aspiration procedure itself.
Methods   From a total of 23 donors, we aimed to take 2 con-
secutive 10-mL aspirates from the same site in 17 donors and in 
6 donors we aimed to take a 5-mL and a 20-mL aspirate. The 
aspiration was stopped either when the syringe was full or when 
no  more  bone  marrow  came  through.  Mononuclear  cell  yield 
(MNC), MSC yield, and differentiation capacity were analyzed 
for intra-donor and inter-donor variation. We analyzed the effect 
of the dilution with peripheral blood by drawing 20 mL at once. 
Results   There was a high correlation between the first and 
second aspiration volumes, and aspirates with a volume of less 
than 8 mL showed a large variation in cellular yield. The second 
10-mL  aspirate,  and  also  20-mL  aspirates,  contained  a  lower 
concentration of nucleated cells and yielded lower numbers of 
mesenchymal stem cells. No effect of the aspiration procedure on 
the biological characteristics of the mesenchymal stem cells was 
seen. 
Conclusion   We recommend collection volumes of bone marrow 
aspirates of at least 8 mL to reduce the risk of obtaining aspirates 
with low cell numbers. From the same site, a second aspiration or 
an aspirate of > 10 mL can be drawn without any loss of biological 
quality due to dilution with peripheral blood.  

 
Bone  tissue  engineering  aims  to  present  an  alternative  for 
autologous transplantation by using human mesenchymal stem 
cells (hMSCs), which form functional bone upon implanta-
tion (Caplan 1991, Bianco and Robey 2001). In bone tissue 
engineering, hMSCs are usually isolated from bone marrow 
aspirates, induced into the osteogenic lineage in vitro using 
dexamethasone, and seeded onto 3-dimensional ceramic scaf-
folds (Caplan 1991). We and others have reported large inter-
donor variation in the concentration of nucleated cells and in 
multi-lineage differentiation potential (Phinney et al. 1999, 
Siddappa et al. 2007), which hampers standardization of the 
bone tissue engineering protocol. The success of cell-based 
bone tissue engineering depends on obtaining a bone marrow 
aspirate with a high yield and quality of hMSCs. We have 
found that the MNC and hMSC yield of a given bone marrow 
aspirate may vary between surgeons (unpublished data). We 
therefore  investigated  whether  the  aspiration  process  itself 
might be a source of inter-donor variation.
Material and methods
Donors
The 23 donors (7 men) were included after obtaining writ-
ten informed consent. All donors were undergoing total hip 
arthroplasty due to coxarthrosis, except for one donor who had 
a fracture of the femoral neck. The mean age was 66 (22–82) 
years.
Isolation and culture of hMSCs
2 consecutive bone marrow aspirates per donor were obtained 
from the supra-acetabular sulcus. 2 aspirates of 10 mL each 
were taken from 17 donors using 10-mL syringes, and in addi-
tion to this a 5-mL and a 20-mL aspirate were taken from each 
of 6 other donors (using 10-mL and 20-mL syringes, respec-
tively). The aspiration process was stopped when the syringe 
was full or when no more bone marrow came through. There 
was about half a minute between the first and second aspiration. 
hMSCs were isolated and proliferated as described previously 
(de Bruijn et al. 1999). hMSC basic medium was composed of 
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medium was composed of hMSC basic medium supplemented 
with 10-8 M dexamethasone. hMSC cell numbers were deter-
mined  using  a  Bürker-Türk  counting  chamber.  Results  are 
given with 95% confidence intervals of the difference between 
group means (CI). Data were analyzed using t-test with paired 
comparison for means or Wilcoxon signed-ranks test when the 
data were skewed (2 observations per donor).
Proliferation assay
To assess hMSC proliferation, cells from 9 donors were seeded 
in triplicate in basic medium at 5,000 cells/cm2 in T25 tissue 
culture flasks. They were trypsinized when approaching con-
fluence. Cell numbers were determined and proliferation was 
expressed as the number of population doublings per day. The 
means of triplicate determinations were analyzed using t-test 
with paired comparison for means (18 observations from 9 
donors).
Alkaline phosphatase (ALP) analysis by flow cytometry 
hMSCs from 9 donors were seeded at 1,000 cells/cm2. Each 
experiment was performed in triplicate with a negative control 
(basic medium) and a positive control (osteogenic medium). 
Expression levels of ALP were analyzed on a FACS Calibur as 
described previously (de Boer et al. 2004). The means of each 
triplicate were analyzed using one-way ANOVA followed by 
Tukey’s post hoc test (36 observations from 9 donors).
Results
Site-dependent aspiration volume
We tried to collect 2 consecutive 10-mL aspirates of bone 
marrow from the same site, but noted that sometimes only a 
small volume could be aspirated. In 15 of the 34 aspirations 
(17 donors) we could only aspirate up to 8 mL. There was a 
high correlation between the volumes of the first and second 
aspirates from each donor (Figure 1).
The influence of the aspirate volume on the concen-
tration of nucleated cells
The aspirates that were less than 8 mL yielded a low concen-
tration of MNCs (Figure 2). In contrast, when the aspiration 
volume was above 8 mL, the concentration of nucleated cells 
was 2.6 × 107 (SD 0.9 × 107) nucleated cells/mL (23 of 34 
aspirations; 2 aspirations per donor).
Multiple aspirations from the same site is associated 
with reduced concentration of nucleated cells
The first aspirate had a higher concentration of MNCs than the 
second aspirate from the same site: 2.7 × 107 (SD 1.0 × 107) 
versus 2.0 × 107 (SD 0.6 × 107) MNCs/mL (95%CI: 1.4 × 106 
– 1.7 × 107, p = 0.003) (Figure 3). We believe that peripheral 
blood preferentially refills the drained marrow cavity, due to 
its lower viscosity than bone marrow. To confirm this, from 6 
donors we isolated 5-mL and 20-mL aspirates from the same 
site consecutively. The 20-mL aspirates were obtained in one 
Figure  1.  Correlation  between  the  first  and 
second  aspiration  volumes.  Scatter  plot  of 
the  first  and  second  aspiration  volumes. 
The correlation coefficient (Spearman’s rho) 
is extremely high at 78% (CI: 48–92) but it 
should be noted that the correlation around 
10 mL is artificial because the volume of the 
syringe was 10 mL.
Figure 2. The effect of aspiration volume on 
the  concentration  of  nucleated  cells.  Scat-
ter plot of the aspiration volume against the 
concentration of nucleated cells. With higher 
aspiration volumes (> 8 mL), the concentra-
tion  does  not  appear  to  increase. The  con-
centrations seem to level off around the mean 
in the higher aspiration volumes. The mean 
concentration is 2.3 × 107 (geometric mean). 
The 4 highest values are not within the 95% 
confidence interval. 
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Figure 3. Concentration of nucleated cells 
per aspiration. Box plots showing the con-
centration of nucleated cells per mL in the 
first  and  the  second  aspirate  with  their 
range,  first  and  third  quartile,  and  mean. 
The second 10-mL aspirate contained 26% 
fewer cells on average than the first aspi-
rate. Outlier depicted separately (°).
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effort. The first aspiration of 5 mL resulted in 4.4 × 107 MNCs/
mL (SD 1.8 × 107) while the second (20-mL) aspirates yielded 
a lower concentration of 2.4 × 107 (SD 1.1 × 107) MNCs/mL 
(95%CI: 1.1 × 107 – 2.9 × 107, p = 0.03) (Figure 4). 
Multiple aspirations from the same site gave reduced 
yield of hMSCs
The numbers of hMSCs obtained from the first and second 
aspirations were grouped according to donor (Figure 5). On 
average,  the  second  aspiration  contained  33%  less  hMSCs 
than the first, which was not statistically significant (95%CI: 
-2.7 × 106 – 8.0 × 106).
Growth rate of hMSCs isolated from different aspirates
The  hMSCs  obtained  from  2  consecutive  10-mL  aspirates 
from 9 donors did not show statistically significant differences 
in their growth rate in vitro (95%CI: -0.15–0.18) (Figure 6). 
Moreover,  there  was  no  statistically  significant  correlation 
between aspiration volume and growth rate of hMSCs (data 
not shown).
Osteogenic differentiation of hMSCs isolated from 
different aspirates
We observed a donor-dependent percentage of ALP-positive 
cells in untreated and dexamethasone-treated hMSCs (Figure 
7). The mean percentage of ALP-positive cells was 21% (2–
46) in both untreated groups whereas dexamethasane induc-
tion resulted in a mean of 44% (3–68) ALP-positive cells. 
Both basic and dex-induced ALP expression was lower in the 
second aspiration; however, no statistically significant differ-
ences were observed (95%CI: -0.37–15). We also analyzed the 
ALP expression per hMSC, which still showed no statistically 
significant difference in ALP expression (data not shown).
Figure 4. Larger aspiration volumes are associ-
ated with reduced concentrations of nucleated 
cells.  Box  plots  showing  the  concentration  of 
nucleated cells per mL for the 5-mL and 20-mL 
aspirates with their range, first and third quar-
tile, and mean. There was a statistically signifi-
cant decrease in concentration of MNCs in the 
20-mL aspirate. 
Figure 5. Mesenchymal stem cells from the 
first and second aspirates. Box plots show-
ing range, first and third quartile, and median 
for the number of mesenchymal cells derived 
from the first and second aspirates. Outliers 
are depicted separately (* and o). After natu-
ral logarithmic transformation due to positively 
skewed data, there was no significant differ-
ence between the numbers of mesenchymal 
cells in the first and second aspirates. 
Figure 6. Proliferation rates of the first and 
second aspiration. Mean proliferation rates 
for the first and second aspirates. Almost 
no  error  was  observed  and  there  were 
only small differences between aspirates. 
These  differences  were  not  significantly 
different from each other. 
Figure 7. ALP induction per donor. The y-axis shows the percentage of 
ALP-positive cells gated in flow cytometric analysis. Box plots show the 
mean ALP levels for triplicate measurements from all donors combined 
for each modality. The range, first and third quartile, and the median are 
shown. Outliers are depicted separately (o). One-way ANOVA followed 
by Tukey’s post hoc test showed no significant differences between the 
ALP levels of the first and second aspirates.
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Discussion
Each aspiration site has its own volume
Among other variables, the number of hMSCs seeded on the 
scaffold is indicative of the osteo-inductivity of a graft (Herni-
gou et al. 2006). Bone marrow is a substance between the 
sinusoids of spongy bone, which is organized in trabeculae. 
Trabeculae  form  crypts  (inter-trabecular  spaces). Arterioles 
and venules are only observed in a small proportion of inter-
trabecular spaces. This suggests that each arteriole or venule 
serves several inter-trabecular spaces (Wilkins 1992). The cor-
relation between the lower aspiration volumes for the first and 
second aspirates implies that an aspiration site has a volume of 
its own, and this volume reflects the anatomical shape of the 
underlying intertrabecular space. It could be that the aspira-
tion sites with the lowest volumes are less well interconnected 
to other intertrabecular sites.
Donor variation and reduced cell numbers in the 
second aspirate
When  positioning  the  needle  in  the  bone  marrow,  and  the 
needle is located near a vessel, peripheral blood will be aspi-
rated more easily than when the needle is located away from 
it. Since the concentration of MNCs in the peripheral blood is 
much lower than that in the bone marrow (Ganong 2005), the 
yield of MNCs in this sample will probably be much lower. 
The influence of peripheral blood on the biological 
characteristics of stromal cells
We found that the aspiration volume had no effect on the 
proliferation rate and ALP expression. Studies investigating 
the effect of acidosis and changes in oxygen concentration 
on bone formation have generally used a long exposure time 
(Brandao-Burch et al. 2005, Martin-Rendon et al. 2007). It 
could be that the difference in circumstances was too little to 
cause a difference, because once in culture the differences in 
environmental circumstances are perhaps better equilibrated, 
when the aspirate has been mixed with culture medium. 
In conclusion, we have shown that aspirating twice from the 
same site reduces cell counts (of MNCs and hMSCs) in the 
second aspirate without affecting the biological characteris-
tics, and that a low aspiration volume gives an uncertain cel-
lular yield. Increasing the aspiration volume above 8 mL will 
reduce the cellular concentration of the aspirate to a certain 
extent, but the biological characteristics remain unaffected by 
the admixture of peripheral blood. We would therefore like to 
suggest aspiration of a minimum volume of 8 mL to reduce 
the chance of obtaining an aspirate with low cell counts, with-
out affecting the biological characteristics of the hMSCs. 
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